XNK Therapeutics

Pharmaceutical Manufacturing • Stockholm, Stockholm County, Sweden • 1-10 Employees

Company overview

Headquarters	Hälsovägen 7, Flemingsberg, Stockholm 141 57, SE
Phone number	+465568946601
Website	xnktherapeutics.com
NAICS	3254
SIC	873
Keywords	Biotechnology, Biopharmaceutical, Oncology, Immunotherapy, Cell Therapy, Cellular Therapeutics, Autologous Cell Therapy, Nk Cell Therapy
Founded	2012
Employees	1-10
Socials

Key Contacts at XNK Therapeutics

Agneta Edberg

Member Of The Board Of Directors

Sophronia Turner

Ceo

About XNK Therapeutics

XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer (NK) cell-based cancer therapies. The R&D pipeline targets areas of high unmet medical need within both hematological malignancies and solid tumors. The most advanced product candidate, evencaleucel, is being evaluated in a phase II clinical study in combination with the CD38 monoclonal antibody, isatuximab, as consolidation therapy following stem cell transplantation in newly diagnosed multiple myeloma patients. At the core of XNK is a committed and experienced team that includes world-renowned NK cell experts and pioneers in the field. The company has developed a proprietary technology platform of broad utility and benefits from its tailor-made GMP facility and co-location with the Karolinska Institute and the Karolinska University Hospital. XNK is well positioned to bring transformational autologous NK cell-based therapies and new hope to cancer patients around the world.

XNK Therapeutics revenue & valuation

Annual revenue	$7,000,000
Revenue per employee	$778,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$22,400,000
Total funding	$156,300

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

XNK Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore XNK Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-11-10	9	$156,300

Funding Insights

$156,300

Total funding amount

$156,300

Most recent funding amount

Number of funding rounds

Frequently asked questions

XNK Therapeutics is located in Stockholm, Stockholm County, SE.

You can reach XNK Therapeutics at +465568946601.

XNK Therapeutics was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

XNK Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

XNK Therapeutics has raised a total of $156,300 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at XNK Therapeutics

Agneta Edberg

Member Of The Board Of Directors

Sophronia Turner

Ceo

4.8

40,000 users